Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit By Investing.com

New York, NY–(Newsfile Corp. – December 24, 2024) – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, informs investors that a class action lawsuit has been filed against Cassava Sciences (NASDAQ:), Inc. (“Cassava” or “The Company”) (NASDAQ: SAVA) and certain of its officers.

Class definition

This lawsuit seeks to recover damages from the defendants for alleged violations of federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cassava securities between February 7, 2024 and November 24, 2024, both dates inclusive. (“Class Period”). Such investors are encouraged to join the cause by visiting the firm’s website at bgandg.com/SAVA.

Details of the case

The Complaint alleges that the Defendants made false and misleading statements and/or failed to provide material information regarding the efficacy of Simufilam, Cassava’s lead Alzheimer’s drug candidate. to the ability to treat the disease.The complaint goes on to allege that in November 2024 On the 25th, Cassava announced that simufilam failed to meet its primary and secondary endpoints in a Phase 3 clinical trial.

What’s next?

A class action lawsuit has already been filed. If you would like to review a copy of the Complaint, you may visit the Company’s website at bgandg.com/SAVA, or you may contact Peretz Bronstein, Esq. or its Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.If you have suffered a loss at Cassava, you have until February 10, 2025 to request that the court appoint you as lead claimant Your ability to participate in any recovery does not require you to serve as lead claimant.

No cost to you

We represent investors in class actions on a contingency fee basis, meaning that we will ask the court to reimburse us for out-of-pocket and attorney fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm representing investors in securities fraud classes and shareholder derivative actions.Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us on LinkedIn, X, Facebook (NASDAQ:) or Instagram for updates.

Advertising of lawyers. Past results do not guarantee similar results.

To view the original version of this press release, visit https://www.newsfilecorp.com/release/233677